A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.
Also called NCT01644201
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- InovoBiologic Inc.
- Registry
-
NCT01644201
-
- Other papers using this trial's data
- Effect of a functional fibre supplement on glycemic control when added to a year-long medically supervised weight management program in adults with type 2 diabetes
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Terminated
Technical summary
Registry record NCT01644201. Randomized; quadruple masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2016-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics
- Condition
- Type II Diabetes Mellitus
- Condition
- Obesity
- Intervention (Dietary supplement)
- PolyGlycopleX® - PGX®
- Intervention (Dietary supplement)
- Rice Flour (placebo)
- Lead sponsor
- InovoBiologic Inc.
Record details
- Record id
cardio:ct-nct01644201- Content hash
c30a0af620e0537c8b21ffa0b6f4fff3367778cf377978c4f2635960c1eb17fd